NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-91

  1. 97 Posts.
    lightbulb Created with Sketch. 13
    Weekly Thursday reminder - Phase 3 trial last patient 9 weeks down 3 weeks to go. (I know this doesn't mean results will be announced in 3 weeks)
    Surely someone has to pull the trigger soon and send the price back up!

    Shouldn't they have around $37m cash in the bank after the placements and September cashflow?
    Short term risk vs reward is good enough for me.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.